Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Cantor Fitzgerald
Teva
Colorcon
Fish and Richardson
Fuji
McKesson
McKinsey
Baxter

Generated: February 21, 2018

DrugPatentWatch Database Preview

Loxapine - Generic Drug Details

« Back to Dashboard

What are the generic sources for loxapine and what is the scope of loxapine patent protection?

Loxapine
is the generic ingredient in five branded drugs marketed by Galen Uk , Actavis Labs Ut Inc, Elite Labs Inc, Lannett Holdings Inc, Mylan, and Watson Labs, and is included in eleven NDAs. There are eighteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Loxapine has two hundred and twenty-four patent family members in twenty countries.

There are eight drug master file entries for loxapine. Two suppliers are listed for this compound.
Summary for loxapine
Medical Subject Heading (MeSH) Categories for loxapine

US Patents and Regulatory Information for loxapine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc LOXITANE loxapine succinate TABLET;ORAL 017525-006 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Watson Labs LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 072204-001 Jun 15, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett Holdings Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 090695-003 Sep 26, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Galen Uk ADASUVE loxapine POWDER;INHALATION 022549-001 Dec 21, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Mylan LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076762-004 Nov 1, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for loxapine

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,498,019 Delivery of compounds for the treatment of headache through an inhalation route ➤ Sign Up
7,087,218 Delivery of diazepam through an inhalation route ➤ Sign Up
7,008,615 Delivery of anti-migraine compounds through an inhalation route ➤ Sign Up
7,078,016 Delivery of caffeine through an inhalation route ➤ Sign Up
7,108,847 Delivery of muscle relaxants through an inhalation route ➤ Sign Up
7,470,421 Delivery of diazepam through an inhalation route ➤ Sign Up
6,783,753 Delivery of antidepressants through an inhalation route ➤ Sign Up
6,805,854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route ➤ Sign Up
6,682,716 Delivery of aerosols containing small particles through an inhalation route ➤ Sign Up
7,033,575 Delivery of physiologically active compounds through an inhalation route ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for loxapine

Supplementary Protection Certificates for loxapine

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90040-2 Sweden ➤ Sign Up PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001 20130220
2013 00046 Denmark ➤ Sign Up PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220
3 Finland ➤ Sign Up
2013 00046 Denmark ➤ Sign Up PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001-002 20130220
0609 Netherlands ➤ Sign Up PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
00609 Netherlands ➤ Sign Up PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
US Army
Medtronic
Chubb
Queensland Health
Moodys
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot